UE LifeSciences Overview

  • Founded

  • 2009

Founded
  • Status

  • Private

  • Employees

  • 70

Employees
  • Latest Deal Type

  • 2ndary - Private

  • Investors

  • 9

UE LifeSciences General Information

Description

Developer of a healthcare technology research platform designed to offer non-invasive breast cancer detection devices. The company's platform offers a portable screening device that helps in the early-stage detection of breast cancer, enabling patients to get early treatments and a cure for cancer.

Contact Information

Website
www.uelifesciences.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Primary Office
  • 3401 Market Street
  • Suite 200
  • Philadelphia, PA 19104
  • United States
+1 (267) 000-0000

UE LifeSciences Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

UE LifeSciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Secondary Transaction - Private 01-Nov-2022 00.000 Completed Generating Revenue
7. Later Stage VC 23-Nov-2021 00000 00.000 Completed Generating Revenue
6. Grant 18-May-2018 00000 00.00 Completed Generating Revenue
5. Later Stage VC 04-Oct-2016 00.00 00.00 Completed Generating Revenue
4. Later Stage VC (Series A) 14-Sep-2015 000 00.00 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2014 0000 00000 Completed Generating Revenue
2. Grant 21-Aug-2012 $878K $150K Completed Generating Revenue
1. Angel (individual) 01-Jan-2009 $150K $150K Completed Startup
To view UE LifeSciences’s complete valuation and funding history, request access »

UE LifeSciences Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series AA-2 000 00.000000 00000.00 00000.00 00 00000.00 0.000
Series AA-1 000 00.000000 00000.00 00000.00 00 00000.00 0.000
Series A2 769 $0.000010 $585.18 $585.18 1x $585.18 4.67%
Series A1 3,077 $0.000010 $812.48 $812.48 1x $812.48 18.69%
To view UE LifeSciences’s complete cap table history, request access »

UE LifeSciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a healthcare technology research platform designed to offer non-invasive breast cancer detection devices. T
Diagnostic Equipment
Philadelphia, PA
70 As of 2022
00.000
00000000000 00.000

000000

olore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco l
0000000000 000000000
Bristol, United Kingdom
00 As of 0000
000.00
000000 - 000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

UE LifeSciences Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
0000000 Venture Capital-Backed Bristol, United Kingdom 00 000.00 000000 - 000 000.00
You’re viewing 1 of 1 competitors. Get the full list »

UE LifeSciences Patents

  • 3

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

UE LifeSciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020314838-A1 System and method for measuring tissue parameters by use of capacitive tactile sensor Pending 17-Jul-2019 0000000000
CA-3147421-A1 System and method for measuring tissue parameters by use of capacitive tactile sensor Pending 17-Jul-2019 0000000000
EP-3999167-A1 System and method for measuring tissue parameters by use of capacitive tactile sensor Pending 17-Jul-2019 A61B5/0053

UE LifeSciences Executive Team (4)

Name Title Board Seat Contact Info
Mihir Shah Co-Founder, Chief Executive Officer, Board Member & President
Bhaumik Sanghvi Co-Founder and Chief Operating Officer
Matthew Campisi Co-Founder and Chief Technology Officer
Madhu Kumar Chief Business Officer
To view UE LifeSciences’s complete executive team members history, request access »

UE LifeSciences Board Members (3)

Name Representing Role Since
Ari Brooks MD UE LifeSciences Board Member 000 0000
Mihir Shah UE LifeSciences Co-Founder, Chief Executive Officer, Board Member & President 000 0000
Suren Gulrajani UE LifeSciences Board Member 000 0000
To view UE LifeSciences’s complete board members history, request access »

UE LifeSciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

UE LifeSciences Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bayer Foundation Impact Investing Minority 000 0000 000000 0
Pfizer Foundation Limited Partner 000 0000 000000 0
Artha Impact Impact Investing Minority 000 0000 000000 0
Carica Investments Other Minority 000 0000 000000 0
Kiran Mazumdar-Shaw Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial